Morgan Group Holding Co. (MGHL)
OTC PINK OTC PINK Primary 
Morgan Stanley Q4 Review: Strong Fundamentals Priced In (Downgrade)
Morgan Stanley delivered strong Q4 results, with 10% revenue growth and 21.8% return on tangible common equity. MS's wealth management business drove record advisory revenue, robust inflows, and margin expansion, reinforcing its fee-based, recurring revenue model. The bank's capital position remains excellent, supporting ongoing buybacks and a secure 2.2% dividend yield.
Morgan Stanley tops estimates driven by wealth management
CNBC's Leslie Picker reports on the company's quarterly earnings results.
Morgan Stanley is about to report earnings. Here's what to expect
Stocks are trading at record highs, which could provide a boost to Morgan Stanley's massive wealth management business.
Ascentage Pharma Group International (AAPG) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Ascentage Pharma Group International (AAPG) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Xvivo Perfusion AB (publ) (XVIPY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Xvivo Perfusion AB (publ) (XVIPY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Zealand Pharma A/S (ZLDPF) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Zealand Pharma A/S (ZLDPF) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Medline Inc. (MDLN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Medline Inc. (MDLN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Omada Health, Inc. (OMDA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Omada Health, Inc. (OMDA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
JP Morgan cautious ahead of reporting season in oil sector
Analysts at JPMorgan repeated a cautious stance on European oil and gas equities into 4Q reporting season, with the American bank highlighting a more challenging 2026 backdrop as oversupply risks are seen as building. The bank also flagged valuation and expectations.
Swedish Orphan Biovitrum AB (publ) (SWOBY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Swedish Orphan Biovitrum AB (publ) (SWOBY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
HeartFlow, Inc. (HTFL) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
HeartFlow, Inc. (HTFL) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Sionna Therapeutics, Inc. (SION) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Sionna Therapeutics, Inc. (SION) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
